Supplemental New Drug Application Submitted For Potential Acute Myeloid Leukemia Treatment
According to a story from PR Newswire, the biopharmaceutical company AbbVie has recently announced that it has sent a supplemental New Drug Application to the FDA for its product venetoclax,…